MORRIS PLAINS, N.J., May 26, 2009 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced five presentations on the Company’s product candidates will occur at the 2009 Annual Meeting of the American Society of Clinical Oncology (ASCO) held in Orlando, Florida, from May 29 - June 2, 2009. The schedule and meeting places for the presentations, together with the abstract numbers are listed below:
